MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer

Conclusions From our results we conclude that miR-613 may act as a tumor suppressor in NSCLC and may serve as a tool for miRNA-based NSCLC therapy.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research